Data as of Q4 2025 (Dec 31, 2025)
โณ
Showing Q3 2025 data
Qiming U.S. Ventures Management, LLC's Q4 2025 filing not yet available. Expected by Feb 14, 2026.

Qiming U.S. Ventures Management, LLC

โ€ขCIK: 1909617โ€ขFiling: Q3 2025

**Qiming U.S. Ventures Management, LLC** manages $56M across a concentrated portfolio of four positions. The fund exhibits significant conviction in its top holdings, led by a substantial allocation to UBS at $35.5M. Further notable positions include KRRO at $17.6M, alongside smaller, targeted investments in JSPR ($2.2M) and KZR ($0.3M). This structure suggests a focused, high-conviction approach within the U.S. market.

Total AUM
$55.6M
QoQ Performance
+135.6%
Positions
4
Top 10 Concentration
100.0%
Latest Filing
Q3 2025

Top Holdings Allocation

TOUR
KRRO
TOURMALINE63.8%
KRRO31.7%
JSPR4.0%
KZR0.6%

๐Ÿ“ˆ Biggest Buys

No new positions or increases this quarter

๐Ÿ“‰ Biggest Sells

No reductions this quarter

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q2 2025

VTYXUSD
VENTYX BIOSCIENCES INC
SOLD
$882.2K
โ€”
HILLEVAX INC
SOLD
$741.5K

Historical Filings

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023